AIDS support program targeting transgendered inmates in 4 French prisons.

Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

AIDS support program targeting transgendered inmates in 4 French prisons.

Int Conf AIDS. 1998;12:927 (abstract no. 43418). Unique Identifier : AIDSLINE ICA12/98405046
Tuahiva M; Cabral C; Heyman L; Rebocho J

Abstract: ISSUE: Support of transgenders health in jail can be improved with a partnership project with jail staff and transgender community groups. PROJECT: PASTT (Prevention Action Health for Transgenders), AIDES PARIS and ACT UP--PARIS have created a work group about isolation of transgenders bringing a specific support such as hormonotherapy, psychological support, health access, counseling about HIV and gender identity, and also safe sex and harm reduction informations. Visiting program is set up for wanted transgenders. The support is also carried out by mail, financial. PASTT intervened concerning gender identity by specialist doctor for jail staff. RESULTS: 1. 4 prisons have been involved: Fleury-Merrogis, Fresnes, La Sante and Villepinte. 2. 35 transgenders have been contacted in these jails: 27 in Fleury-Merrogis, 5 in Fresnes, 2 in La Sante and 1 in Villepinte. 7 had french nationality and 28 were migrants. 31 received a financial support. PASTT received 35 letters from transgenders in jail. 14 transgenders have been supported after their day out. CONCLUSION: Female and male transgenders have specific needs specially because of gender identity problems. Dramatic isolation and deficiency concerning a specific support for transgenders in jail can be decreased with a common work joining as much staff jail as associations where transgenders are represented.

Keywords: MEETING ABSTRACTS *Acquired Immunodeficiency Syndrome Female France Health Services Needs and Demand Human Interpersonal Relations Male *Prisons *Social Support *Transsexualism
981230
M98C1852

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .